Skip to main content
Other
A Pilot, Randomized, Double-Blind, Placebo-Controlled Phase I Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Types 1,2,3,and 6
(2008)
  • Kelly L. Sullivan, Georgia Southern University
Disciplines
Publication Date
2008
Citation Information
Kelly L. Sullivan (Epidemiologist & Project Manager), "A Pilot, Randomized, Double-Blind, Placebo-Controlled Phase I Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Types 1,2,3,and 6," Pfizer and Bobby Allison Ataxia Research Center (Investigator Initiated). (2008-2011).